What Hurt Boston Scientific Corporation (BSX) in Q2 Boston Scientific Corporation, a leading player in the medical technology industry, has been experiencing difficulties that have impacted its stock price.
The company's quarterly results and CHAMPION AF data fell short of expectations, causing its stock to decline.
The healthcare sector as a whole has underperformed in recent times, according to TCW Concentrated Large Cap Growth Fund's Q2 2026 investor letter.